REbif FLEXible Dosing in Early Multiple Sclerosis (MS)

NCT00404352 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

517

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: RNF
DRUG: RNF
DRUG: Placebo

Sponsor

Merck KGaA, Darmstadt, Germany